286 related articles for article (PubMed ID: 18995842)
1. The SIRT2 deacetylase regulates autoacetylation of p300.
Black JC; Mosley A; Kitada T; Washburn M; Carey M
Mol Cell; 2008 Nov; 32(3):449-55. PubMed ID: 18995842
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
[TBL] [Abstract][Full Text] [Related]
4. Autoacetylation regulates P/CAF nuclear localization.
Blanco-García N; Asensio-Juan E; de la Cruz X; Martínez-Balbás MA
J Biol Chem; 2009 Jan; 284(3):1343-52. PubMed ID: 19015268
[TBL] [Abstract][Full Text] [Related]
5. A mechanism for coordinating chromatin modification and preinitiation complex assembly.
Black JC; Choi JE; Lombardo SR; Carey M
Mol Cell; 2006 Sep; 23(6):809-18. PubMed ID: 16973433
[TBL] [Abstract][Full Text] [Related]
6. Acetylation regulates subcellular localization of eukaryotic translation initiation factor 5A (eIF5A).
Ishfaq M; Maeta K; Maeda S; Natsume T; Ito A; Yoshida M
FEBS Lett; 2012 Sep; 586(19):3236-41. PubMed ID: 22771473
[TBL] [Abstract][Full Text] [Related]
7. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
Arif M; Kumar GV; Narayana C; Kundu TK
J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
[TBL] [Abstract][Full Text] [Related]
8. CBP/p300-mediated acetylation of histone H3 on lysine 56.
Das C; Lucia MS; Hansen KC; Tyler JK
Nature; 2009 May; 459(7243):113-7. PubMed ID: 19270680
[TBL] [Abstract][Full Text] [Related]
9. Deacetylation of phosphoglycerate mutase in its distinct central region by SIRT2 down-regulates its enzymatic activity.
Tsusaka T; Guo T; Yagura T; Inoue T; Yokode M; Inagaki N; Kondoh H
Genes Cells; 2014 Oct; 19(10):766-77. PubMed ID: 25195573
[TBL] [Abstract][Full Text] [Related]
10. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.
North BJ; Marshall BL; Borra MT; Denu JM; Verdin E
Mol Cell; 2003 Feb; 11(2):437-44. PubMed ID: 12620231
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and mass spectrometric analysis of p300 histone acetyltransferase domain autoacetylation.
Karanam B; Jiang L; Wang L; Kelleher NL; Cole PA
J Biol Chem; 2006 Dec; 281(52):40292-301. PubMed ID: 17065153
[TBL] [Abstract][Full Text] [Related]
12. Deacetylation of cortactin by SIRT1 promotes cell migration.
Zhang Y; Zhang M; Dong H; Yong S; Li X; Olashaw N; Kruk PA; Cheng JQ; Bai W; Chen J; Nicosia SV; Zhang X
Oncogene; 2009 Jan; 28(3):445-60. PubMed ID: 18850005
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Human Arylamine
Butcher NJ; Burow R; Minchin RF
Mol Pharmacol; 2020 Aug; 98(2):88-95. PubMed ID: 32487734
[TBL] [Abstract][Full Text] [Related]
14. Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells.
Filon M; Yang B; Purohit TA; Schehr J; Singh A; Bigarella M; Lewis P; Denu J; Lang J; Jarrard DF
Oncotarget; 2023 Jul; 14():738-746. PubMed ID: 37477521
[TBL] [Abstract][Full Text] [Related]
15. SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310.
Rothgiesser KM; Erener S; Waibel S; Lüscher B; Hottiger MO
J Cell Sci; 2010 Dec; 123(Pt 24):4251-8. PubMed ID: 21081649
[TBL] [Abstract][Full Text] [Related]
16. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
[TBL] [Abstract][Full Text] [Related]
17. SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice.
Ren YR; Ye YL; Feng Y; Xu TF; Shen Y; Liu J; Huang SL; Shen JH; Leng Y
Acta Pharmacol Sin; 2021 Nov; 42(11):1834-1846. PubMed ID: 33574568
[TBL] [Abstract][Full Text] [Related]
18. Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release.
Narita T; Ito S; Higashijima Y; Chu WK; Neumann K; Walter J; Satpathy S; Liebner T; Hamilton WB; Maskey E; Prus G; Shibata M; Iesmantavicius V; Brickman JM; Anastassiadis K; Koseki H; Choudhary C
Mol Cell; 2021 May; 81(10):2166-2182.e6. PubMed ID: 33765415
[TBL] [Abstract][Full Text] [Related]
19. Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development.
Lee JH; Yang B; Lindahl AJ; Damaschke N; Boersma MD; Huang W; Corey E; Jarrard DF; Denu JM
ACS Chem Biol; 2017 Nov; 12(11):2804-2814. PubMed ID: 28949514
[TBL] [Abstract][Full Text] [Related]
20. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.
Stankovic-Valentin N; Deltour S; Seeler J; Pinte S; Vergoten G; Guérardel C; Dejean A; Leprince D
Mol Cell Biol; 2007 Apr; 27(7):2661-75. PubMed ID: 17283066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
